rs2234582

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_024426.6(WT1):​c.213G>T​(p.Pro71Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.237 in 1,517,410 control chromosomes in the GnomAD database, including 49,299 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P71P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.31 ( 9730 hom., cov: 31)
Exomes 𝑓: 0.23 ( 39569 hom. )

Consequence

WT1
NM_024426.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:20

Conservation

PhyloP100: -0.0700

Publications

20 publications found
Variant links:
Genes affected
WT1 (HGNC:12796): (WT1 transcription factor) This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015]
WT1-AS (HGNC:18135): (WT1 antisense RNA) This gene is located upstream of the Wilms tumor 1 (WT1) gene; these two genes are bi-directionally transcribed from the same promoter region. This gene is imprinted in kidney, with preferential expression from the paternal allele. Imprinting defects at chromosome 11p13 may contribute to tumorigenesis. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 11-32435148-C-A is Benign according to our data. Variant chr11-32435148-C-A is described in ClinVar as Benign. ClinVar VariationId is 261710.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.07 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.585 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024426.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WT1
NM_024426.6
MANE Select
c.213G>Tp.Pro71Pro
synonymous
Exon 1 of 10NP_077744.4
WT1
NM_024424.5
c.213G>Tp.Pro71Pro
synonymous
Exon 1 of 10NP_077742.3H0Y7K5
WT1
NM_001407044.1
c.213G>Tp.Pro71Pro
synonymous
Exon 1 of 10NP_001393973.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WT1
ENST00000452863.10
TSL:1 MANE Select
c.213G>Tp.Pro71Pro
synonymous
Exon 1 of 10ENSP00000415516.5P19544-7
WT1
ENST00000639563.4
TSL:1
c.213G>Tp.Pro71Pro
synonymous
Exon 1 of 9ENSP00000492269.3P19544-8
WT1
ENST00000332351.9
TSL:1
c.213G>Tp.Pro71Pro
synonymous
Exon 1 of 9ENSP00000331327.5J3KNN9

Frequencies

GnomAD3 genomes
AF:
0.308
AC:
46763
AN:
151664
Hom.:
9719
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.592
Gnomad AMI
AF:
0.0826
Gnomad AMR
AF:
0.192
Gnomad ASJ
AF:
0.244
Gnomad EAS
AF:
0.0677
Gnomad SAS
AF:
0.291
Gnomad FIN
AF:
0.131
Gnomad MID
AF:
0.417
Gnomad NFE
AF:
0.215
Gnomad OTH
AF:
0.311
GnomAD2 exomes
AF:
0.220
AC:
25574
AN:
116068
AF XY:
0.228
show subpopulations
Gnomad AFR exome
AF:
0.619
Gnomad AMR exome
AF:
0.128
Gnomad ASJ exome
AF:
0.272
Gnomad EAS exome
AF:
0.0637
Gnomad FIN exome
AF:
0.131
Gnomad NFE exome
AF:
0.225
Gnomad OTH exome
AF:
0.231
GnomAD4 exome
AF:
0.229
AC:
312903
AN:
1365640
Hom.:
39569
Cov.:
52
AF XY:
0.231
AC XY:
155556
AN XY:
673178
show subpopulations
African (AFR)
AF:
0.609
AC:
17792
AN:
29220
American (AMR)
AF:
0.138
AC:
4713
AN:
34128
Ashkenazi Jewish (ASJ)
AF:
0.268
AC:
6504
AN:
24278
East Asian (EAS)
AF:
0.0807
AC:
2733
AN:
33868
South Asian (SAS)
AF:
0.303
AC:
23480
AN:
77498
European-Finnish (FIN)
AF:
0.135
AC:
4507
AN:
33324
Middle Eastern (MID)
AF:
0.322
AC:
1485
AN:
4608
European-Non Finnish (NFE)
AF:
0.222
AC:
237737
AN:
1071718
Other (OTH)
AF:
0.245
AC:
13952
AN:
56998
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
15957
31914
47871
63828
79785
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8504
17008
25512
34016
42520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.308
AC:
46815
AN:
151770
Hom.:
9730
Cov.:
31
AF XY:
0.301
AC XY:
22361
AN XY:
74180
show subpopulations
African (AFR)
AF:
0.591
AC:
24488
AN:
41402
American (AMR)
AF:
0.192
AC:
2931
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.244
AC:
847
AN:
3466
East Asian (EAS)
AF:
0.0680
AC:
347
AN:
5106
South Asian (SAS)
AF:
0.292
AC:
1404
AN:
4806
European-Finnish (FIN)
AF:
0.131
AC:
1388
AN:
10564
Middle Eastern (MID)
AF:
0.411
AC:
120
AN:
292
European-Non Finnish (NFE)
AF:
0.215
AC:
14554
AN:
67842
Other (OTH)
AF:
0.313
AC:
661
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1392
2784
4175
5567
6959
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.271
Hom.:
1311
Bravo
AF:
0.321
Asia WGS
AF:
0.228
AC:
787
AN:
3452

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
4
Wilms tumor 1 (4)
-
-
2
Meacham syndrome (2)
-
-
2
Nephrotic syndrome, type 4 (2)
-
-
2
not provided (2)
-
-
1
11p partial monosomy syndrome;C0950121:Drash syndrome;C0950122:Frasier syndrome;CN033288:Wilms tumor 1 (1)
-
-
1
Drash syndrome (1)
-
-
1
Frasier syndrome (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
9.2
DANN
Benign
0.85
PhyloP100
-0.070
PromoterAI
-0.0079
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2234582; hg19: chr11-32456694; COSMIC: COSV60067015; COSMIC: COSV60067015; API